BioLineRx (BLRX) Change in Account Payables (2014 - 2024)
BioLineRx's (BLRX) quarterly Change in Account Payables came in at $711000.0 in Q4 2024, down 77.07% year-on-year from $3.1 million in Q1 2024, and up 221.33% quarter-over-quarter from -$586000.0 in Q3 2024.
BioLineRx (BLRX) Change in Account Payables (2014 - 2024) Analysis & Trends
BioLineRx's Change in Account Payables history runs 11 years deep, the most recent figure standing at $711000.0 for Q4 2024.
- On a quarterly basis, Change in Account Payables fell 77.07% year-over-year to $711000.0 in Q4 2024; TTM through Dec 2024 was -$5.5 million, a 199.93% decrease from a year earlier, with the FY2025 full-year figure at -$3.5 million, up 36.86% from the prior year.
- Change in Account Payables grew to $711000.0 in Q4 2024 per BLRX's latest filing, from -$586000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.1 million in Q4 2023 and bottomed at -$3.5 million in Q1 2024.
- The 5-year median for Change in Account Payables is $180000.0 (2021), against an average of $81117.6.
- Across the five-year window, Change in Account Payables jumped 567.56% in 2022 and sank 1811.71% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at $51000.0 in 2020, then soared by 341.18% to $225000.0 in 2021, then soared by 567.56% to $1.5 million in 2022, then soared by 106.46% to $3.1 million in 2023, then sank by 77.07% to $711000.0 in 2024.
- Per Business Quant, the three latest BLRX Change in Account Payables figures stand at $711000.0 (Q4 2024), -$586000.0 (Q3 2024), and -$2.1 million (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 711,000.00 |
| Dec 31, 2024 | 711,000.00 |
| Sep 30, 2024 | -586,000.00 |
| Sep 30, 2024 | -586,000.00 |
| Jun 30, 2024 | -2.12 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | -3.51 Mn |
| Mar 31, 2024 | -3.51 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 2.13 Mn |
| Sep 30, 2023 | 2.13 Mn |
| Jun 30, 2023 | -111,000.00 |
| Jun 30, 2023 | -111,000.00 |
| Mar 31, 2023 | 394,000.00 |
| Mar 31, 2023 | 394,000.00 |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | -1.29 Mn |
| Sep 30, 2022 | -1.29 Mn |